Mendham, NJ, United States of America

Robert A Lewis

This inventor holds 2 USPTO granted patents. Top assignee: Cell Therapeutics, Inc.. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert A Lewis. Retrieved from https://idiyas.com/inventor/robert-a-lewis-6edyvwwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert A. Lewis

Introduction

Robert A. Lewis is a notable inventor based in Mendham, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Lewis's latest patents include innovative conjugates that combine polyglutamic acid with therapeutic agents. The first patent, titled "Polyglutamic acid-camptothecin conjugates and methods of preparation," provides methods for the preparation and use of these conjugates. This invention aims to enhance the efficacy of therapeutic agents through improved delivery mechanisms.

Career Highlights

Robert A. Lewis is currently associated with Cell Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company focuses on creating novel therapeutic solutions that can address various medical challenges.

Collaborations

Throughout his career, Lewis has collaborated with esteemed colleagues such as Rama Bhatt and Peter De Vries. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Robert A. Lewis is a distinguished inventor whose work in polyglutamic acid conjugates showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…